Molecular structure from independently sourced SMILES

Olaparib 2D structure

Role
Drug
Mechanism class
PARP inhibitor
Aliases
lynparza
InChIKey
FDLYAMZZIXQODN-UHFFFAOYSA-N
Structure checked
2026-10-08
Molecular formula
C24H23FN4O3
Structure source
PubChem
PubChem CID
23725625
InChI Key
FDLYAMZZIXQODN-UHFFFAOYSA-N
FDA / EMA
FDA/EMA
ClinicalTrials.gov
olaparib BRCA

Read the two structures

Compare olaparib and niraparib by their ring arrangements and oxygen-labelled regions. Even when molecules share a clinical class, trace each ring and connection independently. Similar fingerprint regions do not establish identity of the complete structures.

C(=O)–N connectionsFluorine atoms
Differences measured by the selected structure queries
ObservationOlaparibNiraparib
C(=O)–N connections31
Fluorine atoms10

Connect the structural observations with the fingerprint result

The selected query detects three C(=O)–N connections and one fluorine in olaparib, versus one such connection and no fluorine in niraparib. Ring connections are included. We state the query definition rather than mixing this count with an unspecified “amide count”. [Olaparib] · [Niraparib]

Fourteen shared set bits across a union of 88 give 0.159. Members of the same PARP class can show limited overlap in this representation, illustrating why target-class grouping does not establish the same molecular architecture.

No PARP trapping, cellular activity or tissue-distribution measurements enter this calculation. Those questions require separate experimental conditions and results; the fingerprint value cannot replace them.

Calculated structural similarity: 0.159 · Morgan radius 2 / 2048 bits · Tanimoto

Calculation: 14 / (54 + 48 − 14) = 14 / 88 ≈ 0.159. Set-bit counts are not counts of unique atoms or functional groups.

Query definitions and reproducibility
  • C(=O)–N connections: [#6](=[#8])[#7]
  • Fluorine atoms: [F]

RDKit 2025.03.4 · Matches with identical atom sets are counted once. Colours mark atoms and bonds matching selected queries, not a proven shared scaffold or synthesis route.

  1. Read elemental composition from the formulas.
  2. Trace ring and substituent connections in each drawing.
  3. Compare your observations with the fingerprint score calculated under identical settings.
  4. Check stereochemistry and the complete InChIKey in the source records.

The score is fingerprint overlap, not a percentage of efficacy or safety. RDKit

Structure-source check: 2026-10-08 / 2026-10-08 · Editorial update and calculation check: 2026-10-16

Download source structures, queries and bit counts for this comparison (JSON)

StructureMoa editorial · source review 2026-10-08

Molecular identity

Olaparib: independently retrieved PubChem CID 23725625, formula C24H23FN4O3.

How to compare

Compare olaparib and niraparib by their ring arrangements and oxygen-labelled regions. Even when molecules share a clinical class, trace each ring and connection independently. Similar fingerprint regions do not establish identity of the complete structures.

Interpretation limits

The Morgan/Tanimoto score measures fingerprint overlap. It does not establish efficacy, safety, clinical superiority or full stereochemical identity.

SMILES

C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F

Tags

PARP

Related compounds

External IDs · BioMoa

StructureMoa is a chemical-structure exploration tool. Structural similarity, clustering, and SAR relationships are intended for research exploration and do not establish shared potency, selectivity, safety, efficacy, or clinical performance.

Editorial responsibility and corrections

Operated and edited by the independent StructureMoa project. Explanations use AI assistance; structural identity and similarity are checked against source records and calculation tests. Molecular data and clinical or regulatory evidence have separate review scopes.

Source structures
PubChem · CID / SMILES / InChIKey
Calculations and automated checks
RDKit · Morgan / SMARTS
Disclosed specialist review
No separate external specialist review is disclosed. Passing automated tests is not specialist review of clinical claims.

For a correction, include the page URL, molecule name or CID, the field in question and a supporting source. Corrections are checked against sources, and the affected editorial update date is changed when a correction is published. [email protected]